MRC1 and colorectal carcinoma: The current diagnostic approach to identify carriers of pathogenic MMR variants involves immunohistochemical (IHC) testing of CRC or EC tumors for loss of MMR protein expression followed by germline multigene panel testing of the MMR genes [12].